| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $37.4B | $35.6B | $34.9B |
| Cost of Revenue | $23.9B | $22.9B | $23.0B |
| Gross Profit | $13.5B | $12.7B | $12.0B |
| R&D Expense | — | — | — |
| SG&A Expense | $8.3B | $7.9B | $7.5B |
| Operating Income | $5.4B | $4.9B | $4.2B |
| Net Income | $3.8B | $3.5B | $3.2B |
| EPS (Basic) | $5.54 | $5.06 | $4.36 |
| EPS (Diluted) | $5.51 | $5.02 | $4.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $58.3B | $50.6B | $47.5B |
| Current Assets | $15.3B | $14.1B | $16.9B |
| Cash & Equivalents | $4.1B | $3.7B | $6.3B |
| Total Liabilities | $32.9B | $27.8B | $25.8B |
| Current Liabilities | $8.8B | $10.3B | $10.0B |
| Stockholders' Equity | $24.0B | $21.6B | $20.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $5.6B | $5.0B | $5.0B |
| Investing Cash Flow | $-6.0B | $-6.3B | $-2.4B |
| Capital Expenditures | $2.7B | $2.6B | $1.8B |
| Financing Cash Flow | $0.6B | $-1.2B | $-2.4B |